Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 849.40
Bid: 848.00
Ask: 848.40
Change: 7.40 (0.88%)
Spread: 0.40 (0.047%)
Open: 844.00
High: 852.00
Low: 843.20
Prev. Close: 842.00
INF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Informa plc

16 Mar 2018 10:12

RNS Number : 9804H
JPMorgan Securities Plc
16 March 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Informa plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker & Financial Advisor to UBM plc

(d) Date dealing undertaken:

15 March 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, UBM plc

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received (GBP)

Lowest price per unit paid/received

(GBP)

Ordinary Shares

Purchases

 

Sales

363,095

 

557,726

7.2120

 

7.2080

7.1700

 

7.1600

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBP)

Ordinary Shares

Equity Swaps

 

Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short

 

428

 14,813

 6

 10

 162,450

 27,075

 549

 57,718

 3,871

 19

 11,285

 6,599

 74,128

 424

 200

 21,055

 2,068

 14,400

 847

 784

 2,147

 608

 25,791

 1,068

 1,279

 

189

 1,996

 66

 5,074

 7,546

 112

 96,487

 2,596

 6,270

 4,682

 16,167

 1,986

 50,941

 26,708

 509

 18,342

 236

 24,773

 1,786

 763

 5,201

7.1614

7.1691

7.1726

7.1743

7.1805

7.1810

7.1830

7.1852

7.1860

7.1866

7.1874

7.1876

7.1888

7.1898

7.1899

7.1901

7.1911

7.1915

7.1937

7.1938

7.1953

7.1958

7.1960

7.1966

7.1983

 

7.1620

7.1742

7.1824

7.1840

7.1864

7.1882

7.1889

7.1894

7.1931

7.1936

7.1940

7.1945

7.1952

7.1960

7.1962

7.1963

7.1965

7.1966

7.1982

7.1992

7.1996

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBP)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit (GBP)

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(GBP)

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

(GBP)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

16 March 2018

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBGGDXBBBBGIL
Date   Source Headline
7th Dec 202112:00 pmRNSCapital Markets Day - Growth Acceleration Plan II
26th Nov 20213:32 pmRNSHolding(s) in Company
26th Nov 20213:27 pmRNSHolding(s) in Company
17th Nov 20217:00 amRNSTrading Statement & Board Update
1st Oct 20217:00 amRNSBoard Update
5th Aug 20216:19 pmRNSBlock listing Interim Review
5th Aug 20216:07 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNS2021 Half Year Results Statement
3rd Jun 20215:16 pmRNSResult of AGM
3rd Jun 20217:00 amRNSTrading Update
2nd Jun 20214:42 pmRNSDirector/PDMR Shareholding
24th May 20214:08 pmRNSDirector/PDMR Shareholding
30th Apr 202110:45 amRNSNotice of AGM
26th Apr 20217:00 amRNSMarket update on Financial Intelligence
22nd Apr 20217:00 amRNS2020 Full Year Results Statement
1st Apr 202110:15 amRNSTotal Voting Rights
22nd Mar 20213:35 pmRNSDirector/PDMR Shareholding
17th Mar 20219:35 amRNSExtension of Block Listing
3rd Mar 20213:15 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSBoard Update
19th Feb 20219:30 amRNSHolding(s) in Company
12th Feb 20211:15 pmRNSHolding(s) in Company
14th Jan 20217:00 amRNSDirector/PDMR Shareholding
6th Jan 20217:00 amRNSChair Succession
6th Jan 20217:00 amRNS2020 Year-End Update
23rd Dec 202011:24 amRNSGeneral Meeting Update
10th Dec 20201:53 pmRNSGeneral Meeting Date Extension
4th Dec 202010:15 amRNSBlock listing Interim Review
27th Nov 20205:31 pmRNSNotice of GM
11th Nov 20207:00 amRNSCOVID-19 Action Plan Update
29th Sep 20205:13 pmRNSIssue of Debt
25th Sep 20203:51 pmRNSHolding(s) in Company
21st Sep 20207:00 amRNSInforma Half-Year Results & COVID-19 Action Plan
31st Jul 20205:08 pmRNSTotal Voting Rights
3rd Jul 20202:01 pmRNSDirector/PDMR Shareholding
30th Jun 20205:57 pmRNSTotal Voting Rights
18th Jun 20203:03 pmRNSDirector/PDMR Shareholding
12th Jun 202011:25 amRNSResult of AGM
12th Jun 20207:00 amRNSAGM Trading Update
9th Jun 20202:33 pmRNSNotification of Change in AGM Venue
5th Jun 20202:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20203:22 pmRNSBlock Listing Application
29th May 20205:12 pmRNSTotal Voting Rights
14th May 20205:15 pmRNSHolding(s) in Company
12th May 20206:15 pmRNSNotice of AGM
7th May 20204:55 pmRNSHolding(s) in Company
7th May 202012:49 pmRNSAnnual Financial Report
7th May 20209:12 amRNSDirector/PDMR Shareholding
6th May 20208:21 amRNSDirector/PDMR Shareholding
5th May 202010:32 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.